Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond <i>MYD88</i> L265P.

Of note, mast cells had an increasing trend towards high risk and represented the third most abundant immune cell type (mean of low-, intermediate-, and high-risk groups were 17.1%, 21.5% and 24.4%, respectively) ( Figures 3A, B ).

also in 63,971 other papers